Old Web
English
Sign In
Acemap
>
authorDetail
>
Nicole Laferriere
Nicole Laferriere
Institut Gustave Roussy
Medicine
Sorafenib
Kidney cancer
Melanoma
Cancer
3
Papers
432
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Feasibility, acceptability, and efficacy of a proactive telephone intervention to improve toxicity management during chemotherapy.
2016
Journal of Clinical Oncology
Monika K. Krzyzanowska
Cassandra McKay
Heekyung Han
Sonal Gandhi
Nicole Laferriere
Clare L. Atzema
Kelvin K. Chan
Doris Howell
Vishal Kukreti
Yvonne W. Leung
Aliya Pardhan
Sandy Mitchell
Marla Nayer
Mark Pasetka
Jane Yao
Erin Redwood
Show All
Source
Cite
Save
Citations (0)
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.
2009
Journal of Clinical Oncology
Bernard Escudier
Cezary Szczylik
Thomas E. Hutson
Tomasz Demkow
Michael Staehler
F. Rolland
S. Negrier
Nicole Laferriere
Urban J. Scheuring
David Cella
Sonalee Shah
Ronald M. Bukowski
Show All
Source
Cite
Save
Citations (424)
Comparison of kidney cancer symptoms and quality of life (QoL) in renal cell cancer (RCC) patients (pts) receiving sorafenib vs interferon-α (IFN)
2008
Journal of Clinical Oncology
Cezary Szczylik
David Cella
T. Eisen
Sonalee Shah
Nicole Laferriere
U. J. Scheuring
B. Escudier
Show All
Source
Cite
Save
Citations (8)
1